Publications
Found 13 results
Filters: Author is B. Hu [Clear All Filters]
“Daidzein promotes osteoblast proliferation and differentiation in OCT1 cells through stimulating the activation of BMP-2/Smads pathway”, vol. 15, p. -, 2016.
, “Daidzein promotes osteoblast proliferation and differentiation in OCT1 cells through stimulating the activation of BMP-2/Smads pathway”, vol. 15, p. -, 2016.
, , , “MicroRNA-122 is involved in oxidative stress in isoniazid-induced liver injury in mice”, vol. 14, pp. 13258-13265, 2015.
, “Devolopmental and growth temperature regulation of omega-3 fatty acid desaturase genes in safflower (Carthamus tinctorius L.)”, vol. 13, pp. 6623-6637, 2014.
, “Low-frequency ultrasound induces apoptosis of rat aortic smooth muscle cells (A7r5) via the intrinsic apoptotic pathway”, vol. 13, pp. 3143-3153, 2014.
, “Metastatic renal cell carcinoma to the left maxillary sinus”, vol. 13. pp. 7465-7469, 2014.
, “Analysis of FOS, BTG2, and NR4A in the function of renal medullary hypertension”, vol. 12, pp. 3735-3741, 2013.
, “Enhancement of recombinant adeno-associated virus mediated transgene expression by targeted echo-contrast agent”, vol. 12, pp. 1318-1326, 2013.
, Aoi A, Watanabe Y, Mori S, Takahashi M, et al. (2008). Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med. Biol. 34: 425-434.
http://dx.doi.org/10.1016/j.ultrasmedbio.2007.09.004
PMid:18096302
Bazan-Peregrino M, Arvanitis CD, Rifai B, Seymour LW, et al. (2012). Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model. J. Control Release 157: 235-242.
http://dx.doi.org/10.1016/j.jconrel.2011.09.086
PMid:21982902
Bekeredjian R and Shohet RV (2004). Cardiovascular gene therapy: angiogenesis and beyond. Am. J. Med. Sci. 327: 139-148.
http://dx.doi.org/10.1097/00000441-200403000-00005
PMid:15090752
Bekeredjian R, Chen S, Grayburn PA and Shohet RV (2005). Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med. Biol. 31: 687-691.
http://dx.doi.org/10.1016/j.ultrasmedbio.2004.08.002
PMid:15866418
Bekeredjian R, Kuecherer HF, Kroll RD, Katus HA, et al. (2007). Ultrasound-targeted microbubble destruction augments protein delivery into testes. Urology 69: 386-389.
http://dx.doi.org/10.1016/j.urology.2006.12.004
PMid:17320694
Boussif O, Gaucheron J, Boulanger C, Santaella C, et al. (2001). Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid. J. Gene Med. 3: 109-114.
http://dx.doi.org/10.1002/jgm.166
PMid:11318109
Chu D, Sullivan CC, Weitzman MD, Du L, et al. (2003). Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors. J. Thorac. Cardiovasc. Surg. 126: 671-679.
http://dx.doi.org/10.1016/S0022-5223(03)00082-5
Coura RS and Nardi NB (2007). The state of the art of adeno-associated virus-based vectors in gene therapy. Virol J. 4: 99.
http://dx.doi.org/10.1186/1743-422X-4-99
PMid:17939872 PMCid:2104528
Delalande A, Bureau MF, Midoux P, Bouakaz A, et al. (2010). Ultrasound-assisted microbubbles gene transfer in tendons for gene therapy. Ultrasonics 50: 269-272.
http://dx.doi.org/10.1016/j.ultras.2009.09.035
PMid:19857885
Dijkmans PA, Juffermans LJ, Musters RJ, van Wamel A, et al. (2004). Microbubbles and ultrasound: from diagnosis to therapy. Eur. J. Echocardiogr. 5: 245-256.
http://dx.doi.org/10.1016/j.euje.2004.02.001
PMid:15219539
Edelstein ML, Abedi MR, Wixon J and Edelstein RM (2004). Gene therapy clinical trials worldwide 1989-2004-an overview. J. Gene Med. 6: 597-602.
http://dx.doi.org/10.1002/jgm.619
PMid:15170730
Geis NA, Mayer CR, Kroll RD, Hardt SE, et al. (2009). Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability. Ultrasound Med. Biol. 35: 1119-1126.
http://dx.doi.org/10.1016/j.ultrasmedbio.2009.01.008
PMid:19427103
Harriss DJ and Atkinson G (2011). Update - Ethical standards in sport and exercise science research. Int. J. Sports Med. 32: 819-821.
http://dx.doi.org/10.1055/s-0031-1287829
PMid:22065312
Hiyama A, Mochida J, Iwashina T, Omi H, et al. (2007). Synergistic effect of low-intensity pulsed ultrasound on growth factor stimulation of nucleus pulposus cells. J. Orthop. Res. 25: 1574-1581.
http://dx.doi.org/10.1002/jor.20460
PMid:17593536
Juffermans LJ, Kamp O, Dijkmans PA, Visser CA, et al. (2008). Low-intensity ultrasound-exposed microbubbles provoke local hyperpolarization of the cell membrane via activation of BK(Ca) channels. Ultrasound Med. Biol. 34: 502-508.
http://dx.doi.org/10.1016/j.ultrasmedbio.2007.09.010
PMid:17993242
Kawada T, Nakazawa M, Nakauchi S, Yamazaki K, et al. (2002). Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters. Proc. Natl. Acad. Sci. U. S. A. 99: 901-906.
http://dx.doi.org/10.1073/pnas.022641799
PMid:11805334 PMCid:117403
Lee M, Rentz J, Bikram M, Han S, et al. (2003). Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther. 10: 1535-1542.
http://dx.doi.org/10.1038/sj.gt.3302034
PMid:12907944
Li X, Wang Z, Ran H, Li X, et al. (2008). Experimental research on therapeutic angiogenesis induced by hepatocyte growth factor directed by ultrasound-targeted microbubble destruction in rats. J. Ultrasound Med. 27: 453-460.
PMid:18314523
Melo LG, Agrawal R, Zhang L, Rezvani M, et al. (2002). Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105: 602-607.
http://dx.doi.org/10.1161/hc0502.103363
PMid:11827926
Miura S, Tachibana K, Okamoto T and Saku K (2002). In vitro transfer of antisense oligodeoxynucleotides into coronary endothelial cells by ultrasound. Biochem. Biophys. Res. Commun. 298: 587-590.
http://dx.doi.org/10.1016/S0006-291X(02)02467-1
Müller OJ, Katus HA and Bekeredjian R (2007). Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc. Res. 73: 453-462.
http://dx.doi.org/10.1016/j.cardiores.2006.09.021
PMid:17097076
Müller OJ, Schinkel S, Kleinschmidt JA, Katus HA, et al. (2008). Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats. Gene Ther. 15: 1558-1565.
http://dx.doi.org/10.1038/gt.2008.111
PMid:18615116
Raake PW, Hinkel R, Muller S, Delker S, et al. (2008). Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther. 15: 12-17.
http://dx.doi.org/10.1038/sj.gt.3303035
PMid:17943147
Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, et al. (2004). Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 109: 1029-1035.
http://dx.doi.org/10.1161/01.CIR.0000115519.03688.A2
PMid:14967735
Storek B, Harder NM, Banck MS, Wang C, et al. (2006). Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats. Mol. Pain 2: 4.
http://dx.doi.org/10.1186/1744-8069-2-4
PMid:16445862 PMCid:1373607
Su H, Joho S, Huang Y, Barcena A, et al. (2004). Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts. Proc. Natl. Acad. Sci. U. S. A. 101: 16280-16285.
http://dx.doi.org/10.1073/pnas.0407449101
PMid:15534198 PMCid:527136
Surace EM and Auricchio A (2008). Versatility of AAV vectors for retinal gene transfer. Vision Res. 48: 353-359.
http://dx.doi.org/10.1016/j.visres.2007.07.027
PMid:17923143
Suzuki R, Takizawa T, Negishi Y, Utoguchi N, et al. (2008). Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology. Int. J. Pharm. 354: 49-55.
http://dx.doi.org/10.1016/j.ijpharm.2007.10.034
PMid:18082343
Taylor SL, Rahim AA, Bush NL, Bamber JC, et al. (2007). Targeted retroviral gene delivery using ultrasound. J. Gene Med. 9: 77-87.
http://dx.doi.org/10.1002/jgm.1003
PMid:17310476
Tokunaga N, Nagaya N, Shirai M, Tanaka E, et al. (2004). Adrenomedullin gene transfer induces therapeutic angiogenesis in a rabbit model of chronic hind limb ischemia: benefits of a novel nonviral vector, gelatin. Circulation 109: 526- 531.
http://dx.doi.org/10.1161/01.CIR.0000109700.81266.32
PMid:14732745
Unger EC, Hersh E, Vannan M, Matsunaga TO, et al. (2001). Local drug and gene delivery through microbubbles. Prog. Cardiovasc. Dis. 44: 45-54.
http://dx.doi.org/10.1053/pcad.2001.26443
PMid:11533926
Vassalli G, Bueler H, Dudler J, von Segesser LK, et al. (2003). Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. Int. J. Cardiol. 90: 229-238.
http://dx.doi.org/10.1016/S0167-5273(02)00554-5
Wang JF, Wang JB, Chen H, Zhang CM, et al. (2008). Ultrasound-mediated microbubble destruction enhances gene transfection in pancreatic cancer cells. Adv. Ther. 25: 412-421.
http://dx.doi.org/10.1007/s12325-008-0051-9
PMid:18463802
Wright MJ, Wightman LM, Lilley C, de Alwis M, et al. (2001). In vivo myocardial gene transfer: optimization, evaluation and direct comparison of gene transfer vectors. Basic Res. Cardiol. 96: 227-236.
http://dx.doi.org/10.1007/s003950170053
PMid:11403416
Wu XB, Dong XY and Wu ZJ (2000). A novel technique for adeno-associated virus purification. Chin. Sci. Bull. 45: 2071-2075.
Xu HX, Liu GJ, Lu MD, Xie XY, et al. (2006). Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients. J. Ultrasound Med. 25: 349-361.
PMid:16495496
“Overexpression of HSP27 in cultured human aortic smooth muscular cells reduces apoptosis induced by low-frequency and low-energy ultrasound by inhibition of an intrinsic pathway”, vol. 12, pp. 6588-6601, 2013.
, “Serum lipid abnormalities are not associated with apoB 3' VNTR polymorphism in nephrotic children”, vol. 12, pp. 765-774, 2013.
, Bairaktari E, Hatzidimou K, Tzallas C, Vini M, et al. (2000). Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels. Clin. Biochem. 33: 549-555.
http://dx.doi.org/10.1016/S0009-9120(00)00162-4
Batanian JR, Ledbetter DH and Fenwick RG (1998). A simple VNTR-PCR method for detecting maternal cell contamination in prenatal diagnosis. Genet. Test. 2: 347-350.
http://dx.doi.org/10.1089/gte.1998.2.347
PMid:10464615
Boerwinkle E, Xiong WJ, Fourest E and Chan L (1989). Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region. Proc. Natl. Acad. Sci. U. S. A. 86: 212-216.
http://dx.doi.org/10.1073/pnas.86.1.212
PMid:2911570 PMCid:286434
Choong ML, Koay ES, Khaw MC and Aw TC (1999). Apolipoprotein B 5'-Ins/Del and 3'-VNTR polymorphisms in Chinese, malay and Indian singaporeans. Hum. Hered. 49: 31-40.
http://dx.doi.org/10.1159/000022837
PMid:9858855
Cohen SL, Cramp DG, Lewis AD and Tickner TR (1980). The mechanism of hyperlipidaemia in nephrotic syndrome--role of low albumin and the LCAT reaction. Clin. Chim. Acta 104: 393-400.
http://dx.doi.org/10.1016/0009-8981(80)90398-8
Deka R, Chakraborty R, DeCroo S, Rothhammer F, et al. (1992). Characteristics of polymorphism at a VNTR locus 3' to the apolipoprotein B gene in five human populations. Am. J. Hum. Genet. 51: 1325-1333.
PMid:1463014 PMCid:1682919
Destro-Bisol G, Presciuttini S, d'Aloja E, Dobosz M, et al. (1994). Genetic variation at the ApoB 3'HVR, D2S44, and D7S21 loci in the Ewondo Ethnic Group of Cameroon. Am. J. Hum. Genet. 55: 168-174.
PMid:7912886 PMCid:1918238
Dixit M, Srivastava A, Choudhuri G and Mittal B (2008). Higher alleles of apolipoprotein B Gene 3' VNTR: risk for gallstone disease. Ind. J. Clin. Biochem. 23: 123-129.
http://dx.doi.org/10.1007/s12291-008-0029-z
PMid:23105737 PMCid:3453088
Dixit VM and Hettiaratchi ES (1979). The mechanism of hyperlipidaemia in the nephrotic syndrome. Med. Hypotheses 5: 1327-1331.
http://dx.doi.org/10.1016/0306-9877(79)90102-6
Friedl W, Ludwig EH, Paulweber B, Sandhofer F, et al. (1990). Hypervariability in a minisatellite 3' of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls. J. Lipid Res. 31: 659-665.
PMid:2351870
Gipson DS, Massengill SF, Yao L, Nagaraj S, et al. (2009). Management of childhood onset nephrotic syndrome. Pediatrics 124: 747-757.
http://dx.doi.org/10.1542/peds.2008-1559
PMid:19651590
Gong WK, Cheung W and Yap HK (2000). Minimal change nephrotic syndrome - a complex genetic disorder. Ann. Acad. Med. Singapore 29: 351-356.
PMid:10976389
Gordillo R and Spitzer A (2009). The nephrotic syndrome. Pediatr. Rev. 30: 94-104.
http://dx.doi.org/10.1542/pir.30-3-94
PMid:19255123
Hansen PS, Gerdes LU, Klausen IC, Gregersen N, et al. (1993). Polymorphisms in the apolipoprotein B-100 gene contributes to normal variation in plasma lipids in 464 Danish men born in 1948. Hum. Genet. 91: 45-50.
http://dx.doi.org/10.1007/BF00230221
PMid:8095917
Hokken-Koelega AC, Hackeng WH, Stijnen T, Wit JM, et al. (1990). Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. J. Clin. Endocrinol. Metab 71: 688-695.
http://dx.doi.org/10.1210/jcem-71-3-688
PMid:2394775
Hu P, Lu L, Hu B and Du PF (2009a). Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome. Scand. J. Clin. Lab. Invest. 69: 680-686.
http://dx.doi.org/10.3109/00365510902980751
PMid:19468931
Hu P, Qin YH, Jing CX, Lei FY, et al. (2009b). Association of polymorphisms at restriction enzyme recognition sites of apolipoprotein B and E gene with dyslipidemia in children undergoing primary nephrotic syndrome. Mol. Biol. Rep. 36: 1015-1021.
http://dx.doi.org/10.1007/s11033-008-9275-7
PMid:18512131
Hu P, Qin YH, Jing CX, Lu L, et al. (2009c). Effect of apolipoprotein B polymorphism on body mass index, serum protein and lipid profiles in children of Guangxi, China. Ann. Hum. Biol. 36: 411-420.
http://dx.doi.org/10.1080/03014460902882475
PMid:19449275
Hu P, Qin YH, Hu B and Lu L (2010). Hypervariability in a minisatellite 3' of the apolipoprotein B gene: allelic distribution and influence on lipid profiles in Han Children from central China. Clin. Chim. Acta 411: 2092-2096.
http://dx.doi.org/10.1016/j.cca.2010.09.010
PMid:20837003
Hu P, Wang J, Hu B, Lu L, et al. (2012). Dyslipidemia acts as a close link between cardiovascular risk and renal progression in nephrotic children. Asian Biomed. 6: 151-157.
Huang LS and Breslow JL (1987). A unique AT-rich hypervariable minisatellite 3' to the ApoB gene defines a high information restriction fragment length polymorphism. J. Biol. Chem. 262: 8952-8955.
PMid:2885324
Khrunin A, Verbenko D, Nikitina K and Limborska S (2007). Regional differences in the genetic variability of Finno- Ugric speaking Komi populations. Am. J. Hum. Biol. 19: 741-750.
http://dx.doi.org/10.1002/ajhb.20620
PMid:17691096
Lechner BL, Bockenhauer D, Iragorri S, Kennedy TL, et al. (2004). The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr. Nephrol. 19: 744-748.
http://dx.doi.org/10.1007/s00467-004-1460-x
PMid:15085419
Mitsnefes MM (2008). Cardiovascular complications of pediatric chronic kidney disease. Pediatr. Nephrol. 23: 27-39.
http://dx.doi.org/10.1007/s00467-006-0359-0
PMid:17120060 PMCid:2100430
Noguera NI, Tallano CE, Bragos IM and Milani AC (2000). Modified salting-out method for DNA isolation from newborn cord blood nucleated cells. J. Clin. Lab. Anal. 14: 280-283.
http://dx.doi.org/10.1002/1098-2825(20001212)14:6<280::AID-JCLA6>3.0.CO;2-0
Pan JP, Chiang AN, Chou CY, Chan WL, et al. (1998). Polymorphisms of the apolipoprotein B 3' variable number of tandem repeats region associated with coronary artery disease in Taiwanese. J. Formos. Med. Assoc. 97: 233-238.
PMid:9585673
Pontrelli L, Sidiropoulos KG and Adeli K (2004). Translational control of apolipoprotein B mRNA: regulation via cis elements in the 5' and 3' untranslated regions. Biochemistry 43: 6734-6744.
http://dx.doi.org/10.1021/bi049887s
PMid:15157107
Rantala M, Rantala TT, Savolainen MJ, Friedlander Y, et al. (2000). Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of the role of genetic variation in responsiveness to diet. Am. J. Clin. Nutr. 71: 713-724.
PMid:10702164
Rebhi L, Omezzine A, Kchok K, Belkahla R, et al. (2008). 5' ins/del and 3' VNTR polymorphisms in the apolipoprotein B gene in relation to lipids and coronary artery disease. Clin. Chem. Lab. Med. 46: 329-334.
http://dx.doi.org/10.1515/CCLM.2008.067
PMid:18254714
Ruf RG, Wolf MT, Hennies HC, Lucke B, et al. (2003). A gene locus for steroid-resistant nephrotic syndrome with deafness maps to chromosome 14q24.2. J. Am. Soc. Nephrol. 14: 1519-1522.
http://dx.doi.org/10.1097/01.ASN.0000066141.55735.8D
PMid:12761252
Ruixing Y, Guangqin C, Yong W, Weixiong L, et al. (2007). Effect of the 3'APOB-VNTR polymorphism on the lipid profiles in the Guangxi Hei Yi Zhuang and Han populations. BMC Med. Genet. 8: 45.
http://dx.doi.org/10.1186/1471-2350-8-45
PMid:17640344 PMCid:1939985
Sajantila A, Lukka M and Syvanen AC (1999). Experimentally observed germline mutations at human micro- and minisatellite loci. Eur. J. Hum. Genet. 7: 263-266.
http://dx.doi.org/10.1038/sj.ejhg.5200257
PMid:10196715
Segrest JP, Jones MK, De Loof H and Dashti N (2001). Structure of apolipoprotein B-100 in low density lipoproteins. J. Lipid Res. 42: 1346-1367.
PMid:11518754
Soares-Vieira JA, Billerbeck AE, Iwamura ES, Cardoso L, et al. (2000). Post-mortem forensic identity testing: application of PCR to the identification of fire victim. Sao Paulo Med. J. 118: 75-77.
http://dx.doi.org/10.1590/S1516-31802000000300005
PMid:10810332
Tovar AR, Murguia F, Cruz C, Hernandez-Pando R, et al. (2002). A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J. Nutr. 132: 2562-2569.
PMid:12221209
Verbenko DA, Pogoda TV, Spitsyn VA, Mikulich AI, et al. (2003). Apolipoprotein B 3'-VNTR polymorphism in Eastern European populations. Eur. J. Hum. Genet. 11: 444-451.
http://dx.doi.org/10.1038/sj.ejhg.5200986
PMid:12774037
Wiecek A, Kokot F, Strzelczyk P, Witkowicz J, et al. (1993). Relationship between renal biopsy histopathology and profile of changes in serum protein, lipids and proteinuria in patients with nephrotic syndrome due to chronic glomerulonephritis. Pol. Arch. Med. Wewn. 90: 426-432.
PMid:8146046
Yasuda N and Kimura M (1968). A gene-counting method of maximum likelihood for estimating gene frequencies in ABO and ABO-like systems. Ann. Hum. Genet. 31: 409-420.
http://dx.doi.org/10.1111/j.1469-1809.1968.tb00574.x
PMid:5673164
“Sexual dimorphism of STGC3 tumor suppressor function in nasopharyngeal carcinoma CNE2 cells”, vol. 11, pp. 4585-4597, 2012.
, Abdel Khalek Abdel RA and King A (2012). MRI and CT of nasopharyngeal carcinoma. AJR Am. J. Roentgenol. 198: 11-18.
http://dx.doi.org/10.2214/AJR.11.6954
PMid:22194474
Chae JI, Kim J, Woo SM, Han HW, et al. (2009). Cytoskeleton-associated proteins are enriched in human embryonic-stem cell-derived neuroectodermal spheres. Proteomics 9: 1128-1141.
http://dx.doi.org/10.1002/pmic.200800234
PMid:19206105
Chong VF and Ong CK (2008). Nasopharyngeal carcinoma. Eur. J. Radiol. 66: 437-447.
http://dx.doi.org/10.1016/j.ejrad.2008.03.029
PMid:18485650
Diehl JA, Yang W, Rimerman RA, Xiao H, et al. (2003). Hsc70 regulates accumulation of cyclin D1 and cyclin D1- dependent protein kinase. Mol. Cell Biol. 23: 1764-1774.
http://dx.doi.org/10.1128/MCB.23.5.1764-1774.2003
PMid:12588994 PMCid:151693
Garbuz DG, Astakhova LN, Zatsepina OG, Arkhipova IR, et al. (2011). Functional organization of hsp70 cluster in camel (Camelus dromedarius) and other mammals. PLoS One 6: e27205.
http://dx.doi.org/10.1371/journal.pone.0027205
PMid:22096537 PMCid:3212538
He XS, Xiao ZQ, Chen ZC, Zhao SP, et al. (2004). Molecular cloning and functional analysis of STGC3 - a novel gene on chromosome 3p21. Ai Zheng 23: 1110-1115.
PMid:15473918
He XS, Deng M, Yang S, Xiao ZQ, et al. (2008). The tumor supressor function of STGC3 and its reduced expression in nasopharyngeal carcinoma. Cell Mol. Biol. Lett. 13: 339-352.
http://dx.doi.org/10.2478/s11658-008-0006-9
PMid:18322654
Jensen EV (1966). Mechanism of estrogen action in relation to carcinogenesis. Proc. Can. Cancer Conf. 6: 143-165.
PMid:5973472
Jensen EV (2005). The contribution of "alternative approaches" to understanding steroid hormone action. Mol. Endocrinol. 19: 1439-1442.
http://dx.doi.org/10.1210/me.2005-0154
PMid:15914713
Jensen EV, Suzuki T, Kawashima T, Stumpf WE, et al. (1968). A two-step mechanism for the interaction of estradiol with rat uterus. Proc. Natl. Acad. Sci. U. S. A. 59: 632-638.
http://dx.doi.org/10.1073/pnas.59.2.632
PMid:5238991 PMCid:224719
Li L, He XS, Luo QA, Zhang ZW, et al. (2011). Effect of STGC3 gene deletion mutant on the growth of CNE2 cells. Prog. Biochem. Biophys. 38: 248-253.
Masamha CP and Benbrook DM (2009). Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Cancer Res. 69: 6565-6572.
http://dx.doi.org/10.1158/0008-5472.CAN-09-0913
PMid:19638577
Pollard PJ, Briere JJ, Alam NA, Barwell J, et al. (2005). Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14: 2231-2239.
http://dx.doi.org/10.1093/hmg/ddi227
PMid:15987702
Powers MV, Clarke PA and Workman P (2008). Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell 14: 250-262.
http://dx.doi.org/10.1016/j.ccr.2008.08.002
PMid:18772114
Qiu QC, Hu B, He XP, Luo Q, et al. (2012). STGC3 inhibits xenograft tumor growth of nasopharyngeal carcinoma cells by altering the expression of proteins associated with apoptosis. Genet. Mol. Biol. 35: 18-26.
http://dx.doi.org/10.1590/S1415-47572012005000009
PMid:22481869 PMCid:3313509
Takatani T, Takaoka N, Tatsumi M, Kawamoto H, et al. (2001). A novel missense mutation in human lactate dehydrogenase B-subunit gene. Mol. Genet. Metab. 73: 344-348.
http://dx.doi.org/10.1006/mgme.2001.3203
PMid:11509017
Wang HY, Sun BY, Zhu ZH, Chang ET, et al. (2011). Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival. J. Clin. Oncol. 29: 4516-4525.
http://dx.doi.org/10.1200/JCO.2010.33.7741
PMid:22025164
Xiong W, Zeng ZY, Xia JH, Xia K, et al. (2004). A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res. 64: 1972-1974.
http://dx.doi.org/10.1158/0008-5472.CAN-03-3253
PMid:15026332
Yoneda K, Rokutan K, Nakamura Y, Yanagawa H, et al. (2004). Stimulation of human bronchial epithelial cells by IgE-dependent histamine-releasing factor. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L174-L181.
http://dx.doi.org/10.1152/ajplung.00118.2003
PMid:12948934
Yu MC and Yuan JM (2002). Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol. 12: 421-429.
http://dx.doi.org/10.1016/S1044579X02000858
PMid:12450728
Zhang J, Liu W, Liu J, Xiao W, et al. (2010). G-protein β2 subunit interacts with mitofusin 1 to regulate mitochondrial fusion. Nat. Commun. 1: 101.
http://dx.doi.org/10.1038/ncomms1099
PMid:20981029
Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, et al. (1997). CDK-independent activation of estrogen receptor by cyclin D1. Cell 88: 405-415.
http://dx.doi.org/10.1016/S0092-8674(00)81879-6